3650 results for «372»

Filter By

3650 results

EAPCI General Assembly

22 May 2019 – From EuroPCR 2019

Consult this session to discover the EAPCI General Assembly's slides, presented during EuroPCR 2019. Learn more about the different committees and the grants programme.

EAPCI General Assembly

Treatment of bending zones in femoral and popliteal arteries - LIVE Case

23 May 2019 – From EuroPCR 2019

Consult this session to learn more about the different characteristics of devices and treatment strategies including: directional atherectomy + drug-coated balloon, calcified plaque softening with lithoplasty, new stents conforming to anatomy, and more!

LIVE demonstration from Clinique Pasteur - Toulouse, France

Treatment of bending

TAVI in bicuspid aortic stenosis - LIVE Case

23 May 2019 – From EuroPCR 2019

Consult this session to learn more about TAVI in bicuspid aortic stenosis, thanks a LIVE demonstration from St Thomas Hospital - London, United Kingdom, transmitted during EuroPCR 2019. Discover the case of a 84 years-old male with severe symptomatic aortic stenosis in a functionally bicuspid aortic valve; watch...

TAVI in bicuspid aortic stenosis

LAA Closure - LIVE Case

23 May 2019 – From EuroPCR 2019

Consult this session to learn more about how to efficiently manage LAA closure for stroke prevention, thanks to a compelling LIVE demonstration from Institut Cardiovasculaire Paris Sud, France, during EuroPCR 2019. Discover the case of a 81 years-old female with intracranial hemmorrhage  and multiple cerebral cavernomatosis; watch the treatment...

LAA Closure - LIVE Case

Coronary sinus reducer for microvascular angina

28 Feb 2020

A 61-year-old man with a history of 2-vessel coronary artery stenting, hypertension and type-2 diabetes mellitus was admitted 5 times within September 2017 and November 2018 for recurrent angina CCS class III-IV refractory to therapy with nitrates, b-blockers and ranolazine in maximally tolerated doses...

Coronary sinus reducer for microvascular angina

OPTIMUM: Outcomes of Percutaneous RevascularizaTIon for Management of SUrgically Ineligible Patients with Multivessel or Left Main Coronary Artery Disease

04 Nov 2021

Mirvat Alasnag reviews the OPTIMUM trial, presented by David E. Kandzari, which reports outcomes in a subset of patients who are increasingly seen in modern day catheterization laboratories. It is noteworthy that 1 in 5 patients with left main or multivessel disease are considered surgically ineligible.

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
OPTIMUM: Early Outcomes From a Prospective Registry of PCI in Patients at Prohibitive Risk for CABG

Concomitant left atrial appendage occlusion and transcatheter aortic valve replacement among patients with atrial fibrillation – The WATCH-TAVR Trial

26 Oct 2023

Panos Xaplanteris provides his take on WATCH-TAVR results which were presented by Samir R. Kapadia at TCT Congress 2023.

Safety and Efficacy of Left Atrial Appendage Occlusion at the Time of Transcatheter Aortic Valve Replacement - The WATCH TAVR Trial

Panagiotis Xaplanteris

Author

Panagiotis Xaplanteris
Safety and Efficacy of Left Atrial Appendage Occlusion at the Time of Transcatheter Aortic Valve Replacement - The WATCH TAVR Trial

The FLAVOUR Randomized Clinical Trial: Comparison of Fractional Flow Reserve-guided and Intravascular Ultrasound-guided Percutaneous Coronary Intervention in Intermediate Coronary Artery Stenosis

22 Mar 2022

Daniele Giacoppo analyses the main results of the FLAVOUR trial which were presented by Bon-Kwon Koo, from Seoul National University Hospital, South Korea at the American College of Cardiology 2022. 

Daniele Giacoppo

Author

Daniele Giacoppo
The FLAVOUR Randomized Clinical Trial: Comparison of Fractional Flow Reserve-guided and Intravascular Ultrasound-guided Percutaneous Coronary Intervention in Intermediate Coronary Artery Stenosis

Five-year outcomes of the randomised trial of fractional flow reserve guided PCI compared to coronary artery bypass grafting: FAME 3

02 Apr 2025

Kalaivani Mahadevan provides her take on the five-year outcomes of the FAME 3 trial presented by William F. Fearon at ACC.25 in Chicago.

Kalaivani Mahadevan

Author

Kalaivani Mahadevan
FFR-guided PCI vs CABG: 5-year results of the FAME 3 trial

Harmonising optimal strategy for treatment of coronary artery diseases – bleeding risk: HOST-BR

29 Mar 2025

Daniele Giacoppo and Nicola Ammirabile provide their take on the main results of the HOST-BR trial, presented by Hyo-Soo Kim at ACC.25 in Chicago.

Nicola Ammirabile

Author

Nicola Ammirabile
Daniele Giacoppo

Author

Daniele Giacoppo
Harmonising optimal strategy for treatment of coronary artery diseases – bleeding risk: HOST-BR
Didn’t find what you were looking for?